krblokhin
- Altria comprises over 20% of my dividend stock portfolio, and I am optimistic about its potential, even without cannabis reform.
- I believe Trump may enact federal cannabis reform due to political pragmatism and growing public support, especially among younger Republicans.
- Cannabis reform aligns with states’ rights, appealing to conservatives, moderates, and libertarians, and could ensure continued Republican political dominance.
- Economically, cannabis reform is sensible, with the U.S. industry valued at $30 billion and the potential to double sales by 2028.
Trump has been pivoting towards a pro-cannabis stance heavily since his election campaign and Altria (NYSE:MO) stands to benefit from this development substantially. In August last year, Trump stated that tax dollars shouldn’t be wasted on arresting individuals. Aseity Research blends high-yield income investing with tech-driven growth. We provide actionable insights on stocks, ETFs, CEFs, and options strategies—leveraging dividends and theta-based plays for steady income and strong returns.To read more about our expertise and to get in contact visit AseityResearch.com.
READ FULL ARTICLE HERE!
